Skip to main content
logo
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.29
-0.19 (-1.15%)
At close: Aug 28, 2026, 4:00 PM EDT
16.35
+0.06 (0.37%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Aurinia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
314.11287.25.75-78.02-108.18-180.97
Depreciation & Amortization
19.3819.4519.4511.652.712.76
Loss (Gain) From Sale of Investments
-9.16-10.18-12.73-12.14-1.570.66
Stock-Based Compensation
14.6214.6831.645.3132.331.24
Other Operating Activities
-162.78-166.71-5.125.352.0310.24
Change in Accounts Receivable
-1.05-4.91-12.46-10.611.93-15.42
Change in Inventory
1.35-6.460.48-15.87-9.07-5.64
Change in Accounts Payable
-3.45-1.870.861.24-0.794.08
Change in Unearned Revenue
0.233.675.793.763.05-
Change in Other Net Operating Assets
1.990.810.7815.86-1.93-4.65
Operating Cash Flow
175.24135.6644.39-33.46-79.53-157.69
Operating Cash Flow Growth
89.08%205.62%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.18-0.25-0.28-0.72-0.29-0.3
Sale (Purchase) of Intangibles
------1.2
Investment in Securities
7.81-32.5239.595.88-59.68-84.53
Other Investing Activities
---0.04-11.86-0.66-17.84
Investing Cash Flow
12.84-32.7739.26-6.71-60.63-103.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--13.14-11.99-10.03--
Net Debt Issued (Repaid)
-13.99-13.14-11.99-10.03--
Issuance of Common Stock
63.4714.959.277.173.47221.11
Repurchase of Common Stock
-110.73-107.92-46.37-2.28-1.04-
Financing Cash Flow
-61.25-106.11-49.09-5.132.43221.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
126.83-3.2234.56-45.3-137.73-40.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
175.07135.4144.11-34.18-79.82-158
Free Cash Flow Growth
89.41%206.99%----
Free Cash Flow Margin
56.20%47.84%18.76%-19.47%-59.55%-346.44%
Free Cash Flow Per Share
1.280.980.30-0.24-0.56-1.22
Levered Free Cash Flow
147.8291.4162.94-3.89-35.1-98.48
Unlevered Free Cash Flow
150.3894.1265.96-2.16-35.1-98.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
4.112.822.180.51.980.26
Change in Working Capital
-0.93-8.785.45-5.61-6.82-21.63
SEC Filings: 10-K · 10-Q